Brazil lifts ban on controversial sterilization implants

July 11, 2017

Brazil has lifted a ban on the sale of Essure female sterilization implants after receiving results from clinical trials on its risks, authorities said Tuesday.

Sale of the implants, which was suspended in February, was authorized after its maker Bayer presented documents detailing that had been sought by the Brazilian Health Regulatory Agency (Anvisa).

These included results of that lasted a year or longer as well as a report on measures taken by the maker after a warning by Canada's health agency.

The so-called "permanent birth control" method involves the implantation of a metal coil in each fallopian tube which leads to the build-up of that forms a barrier preventing sperm from reaching eggs.

Acquired by German pharmaceutical firm Bayer in 2013, its use is being scrutinized by a number of countries, including the United States and France since 2015 following a surge of complaints about side effects.

About one million units have been sold worldwide since 2001.

Anvisa said its earlier suspension was brought about by the company's failure to respond to concerns on the product's safety.

Side effects can include changes to the menstrual cycle, unwanted pregnancies, chronic pain, perforations of the uterus and , migration of the device to the abdominal or pelvic cavity and suspected allergic or .

A collective lawsuit against Bayer is set to be filed in France in September by a group of 400 women, a lawyer representing them told AFP, while a Facebook group called "Essure Problems" currently counts more than 33,000 members.

Explore further: Women sue healthcare giant Bayer over contraceptive implants

Related Stories

Women sue healthcare giant Bayer over contraceptive implants

December 9, 2016
French lawyers for women who say a contraceptive implant sold by Bayer Healthcare had caused a string of medical complications launched a lawsuit against the multinational on Friday.

FDA reviewing safety of Essure birth control implant

June 25, 2015
Federal health regulators are reviewing the safety of an implantable contraception device after receiving reports of unusual side effects from patients, including fatigue, depression and weight gain.

FDA explains pros, cons of permanent birth control

November 18, 2016
(HealthDay)—Women need to carefully consider the benefits and risks of permanent birth control devices, the U.S. Food and Drug Administration says.

FDA experts to review safety of Essure birth control implant

September 21, 2015
Federal medical experts will take a closer look at a host of problems reported with the birth control implant called Essure, including chronic pain, bleeding, headaches and allergic reactions.

FDA aims to publish Essure safety review in February

November 24, 2015
Federal health officials aim to release their findings on a much-debated contraceptive implant by the end of February.

FDA petitioned to stop sales of essure implant

May 5, 2015
(HealthDay)—Bayer's contraceptive implant Essure can cause serious complications and should be taken off the market, says a citizen's petition filed with the U.S. Food and Drug Administration.

Recommended for you

RNAi therapy mitigates preeclampsia symptoms

November 19, 2018
A collaboration of scientists from the University of Massachusetts Medical School, Beth Israel Deaconess Medical Center and Western Sydney University, have shown that an innovative new type of therapy using small interfering ...

New blood test detects early stage ovarian cancer

November 19, 2018
Research on a bacterial toxin first discovered in Adelaide has led to the development a new blood test for the early diagnosis of ovarian cancer—a disease which kills over 1000 Australian women and 150,000 globally each ...

Human Cell Atlas study reveals maternal immune system modifications in early pregnancy

November 14, 2018
The first Human Cell Atlas study of early pregnancy in humans has shown how the function of the maternal immune system is affected by cells from the developing placenta. Researchers from the Wellcome Sanger Institute, Newcastle ...

Soy formula feeding during infancy associated with severe menstrual pain in adulthood

November 9, 2018
New research suggests that infant girls fed soy formula are more likely to develop severe menstrual pain as young adults. The finding adds to the growing body of literature that suggests exposure to soy formula during early ...

A major role for a small organ in the immune response during pregnancy

November 9, 2018
The immune system of a pregnant woman is altered during pregnancy, but not in the way previously believed, according to results from a study at Linköping University, Sweden. This study, published in the Journal of Allergy ...

Mailed HPV tests can help find women at-risk for cervical cancer, study finds

November 7, 2018
University of North Carolina Lineberger Comprehensive Cancer Center researchers have found that mailing self-collection kits to test for high-risk human papillomavirus infection has the potential to boost cervical cancer ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.